(Q68184838)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

High-dose folinic acid and 5-fluorouracil plus cisplatin on a weekly schedule in the treatment of advanced cancer of the head and neck (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

1 reference

V Gebbia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

A Russo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

N Gebbia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

L Rausa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

F Ingria

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

G Spatafora

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

G Zerillo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

A Cimino

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

T Pastorello

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

P Ferrara

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

22 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

458-462

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01629430

22 September 2019

exact match

0 references

cites work

Four-day continuous infusion of cisplatin and 5-fluorouracil in head and neck cancer

1 reference

12 December 2020

Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil

1 reference

12 December 2020

Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase

1 reference

12 December 2020

Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate.

1 reference

12 December 2020

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells

1 reference

12 December 2020

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

1 reference

12 December 2020

Head and neck cancer: chemotherapy concepts.

1 reference

12 December 2020

A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck.

1 reference

12 December 2020

Structures of reversible and irreversible complexes of thymidylate synthetase and fluorinated pyrimidine nucleotides.

1 reference

12 December 2020

The role of drug sequence in therapeutic selectivity of the combination of 5-fluorouracil and cis-platin

1 reference

12 December 2020

Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

1 reference

12 December 2020

Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil

1 reference

12 December 2020

Cytotoxicity of 5-fluoro-2'-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate

1 reference

12 December 2020

Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.

1 reference

12 December 2020

cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice

1 reference

12 December 2020

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

1 reference

12 December 2020

A phase I-II study on the toxicity and therapeutic efficacy of 5-fluorouracil in combination with leucovorin and cisplatinum in patients with advanced colorectal carcinoma

1 reference

12 December 2020

A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Cis-diamminodichloroplatinum plus a 5-day continuous infusion of 5-fluorouracil in the treatment of locally recurrent and metastatic head and neck cancer patients

1 reference

12 December 2020

Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin.

1 reference

12 December 2020

Cisplatin and 5-fluorouracil chemotherapy in advanced or recurrent squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis

1 reference

12 December 2020

5-Fluorouracil + folinic acid with cisplatinum and bleomyein in the treatment of advanced head and neck squamous cell carcinoma

1 reference

12 December 2020

Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck

1 reference

12 December 2020

A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer

1 reference

12 December 2020

Continuous cisplatin (24-hour) and 5-fluorouracil (120-hour) infusion in recurrent head and neck squamous cell carcinoma

1 reference

12 December 2020

Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells

1 reference

12 December 2020

Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01629430

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1618894%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference